USANA Health Sciences (USNA) Stock Price

Currency:

USANA Health Sciences Price

🇺🇸NYSE·CLOSED

21.19USD

Market closed

Today +/-

-0.17 USD

Today %

-0.80 %

PRO

USANA Health Sciences (USNA) — ISIN US90328M1071. The USANA Health Sciences stock price was 21.19 USD in 2026. Revenue was 975.3 M USD. Earnings were 36.36 M USD. P/E ratio was 11.16. USANA Health Sciences operates in the Non-cyclical consumption sector.

USANA Health Sciences stock price

Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of USANA Health Sciences over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how USANA Health Sciences stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing USANA Health Sciences's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

USANA Health Sciences Stock Price History

Date	USANA Health Sciences Price
2/26/2026	21.19 USD
2/25/2026	21.36 USD
2/24/2026	21.67 USD
2/23/2026	21.82 USD
2/20/2026	21.93 USD
2/19/2026	20.52 USD
2/18/2026	19.06 USD
2/16/2026	20.66 USD
2/12/2026	20.90 USD
2/11/2026	20.96 USD
2/10/2026	21.14 USD
2/9/2026	21.43 USD
2/8/2026	21.20 USD
2/5/2026	21.34 USD
2/4/2026	20.81 USD
2/3/2026	20.90 USD
2/2/2026	20.44 USD
2/1/2026	21.66 USD

API Docs Get API Key

USANA Health Sciences Revenue, EBIT, Net Income

3 Years
5 Years
10 Years
25 Years
Max

Unlock the full history with 30+ years of data and forecast estimates.

Unlock all data — PRO

Revenue

EBIT

Net Income

Details

API Docs Get API Key

USANA Health Sciences Income Statement, Balance Sheet, Cash Flow Statement

Last updated Mar 3, 2026, 3:42 PM

REVENUE (B USD)

REVENUE GROWTH (%)

GROSS MARGIN (%)

GROSS INCOME (M USD)

NET INCOME (M USD)

NET INCOME GROWTH (%)

SHARES (M)

DOCUMENTS

1994	1995	1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025e	2026e	2027e
0.01	0.02	0.06	0.09	0.13	0.13	0.12	0.11	0.13	0.2	0.26	0.32	0.37	0.42	0.43	0.44	0.52	0.58	0.65	0.72	0.79	0.92	1.01	1.05	1.19	1.06	1.13	1.19	1	0.92	0.85	0.94	0.98	1.04
–	242.86	137.50	54.39	43.18	6.35	-8.21	-7.32	16.67	50.38	29.50	21.62	15.87	15.89	1.42	1.63	18.58	12.38	11.53	10.80	10.03	16.20	9.59	4.08	13.56	-10.85	6.98	4.59	-15.85	-7.72	-7.27	10.42	3.39	6.15
71.43	75.00	77.19	76.14	76.19	77.61	69.92	71.05	75.19	77.50	77.61	78.10	78.08	79.20	79.25	79.59	81.62	82.62	82.10	82.17	82.15	82.57	82.01	82.81	83.10	82.36	81.57	81.62	80.56	80.78	81.15	73.49	71.08	66.96
5	18	44	67	96	104	86	81	100	155	201	246	285	335	340	347	422	480	532	590	649	758	825	867	988	873	925	968	804	744	693	693	693	693
0	2	5	6	9	5	2	2	8	20	30	38	40	45	29	33	45	24	66	79	76	94	100	62	126	100	124	116	69	63	42	32	36	52
–	–	150.00	20.00	50.00	-44.44	-60.00	–	300.00	150.00	50.00	26.67	5.26	12.50	-35.56	13.79	36.36	-46.67	175.00	19.70	-3.80	23.68	6.38	-38.00	103.23	-20.63	24.00	-6.45	-40.52	-8.70	-33.33	-23.81	12.50	44.44
42.5	46.4	53.3	53.3	55.7	49.9	39.6	38.8	41.3	42.6	40.8	39.4	37.4	34.4	32.3	30.9	31.9	31.1	29.8	28.4	27.4	26.4	25	24.7	24.6	22.8	21.3	20.3	19.3	19.35	19.16	19.16	19.16	19.16
–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–

Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales USANA Health Sciences generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue USANA Health Sciences retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare USANA Health Sciences's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares USANA Health Sciences has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against USANA Health Sciences's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

ASSETS

CASH BALANCE (M USD)

RECEIVABLES (k USD)

OTHER RECEIVABLES (M USD)OTHER REC. (M USD)

INVENTORIES (M USD)

OTHER CURRENT ASSETS (M USD)OTHER CURRENT LIAB. (M USD)

CURRENT ASSETS (M USD)

TANGIBLE ASSETS (M USD)

LONG-TERM INVESTMENTS (M USD)LONG-T. INVEST. (M USD)

LONG-TERM RECEIVABLES (M USD)LONG-T. REC. (M USD)

INTANGIBLE ASSETS (M USD)INTANGIBLE ASSETS (M USD)

GOODWILL (M USD)

OTHER NON-CURRENT ASSETS (M USD)OTHER NON-CURRENT ASSETS (M USD)

NON-CURRENT ASSETS (M USD)

TOTAL ASSETS (M USD)

LIABILITIES

COMMON STOCK (M USD)

ADDITIONAL PAID-IN CAPITAL (M USD)

RETAINED EARNINGS (M USD)

OTHER EQUITY (M USD)OTHER EQUITY (M USD)

UNREALIZED GAINS/LOSSES (M USD)UNREAL. GAINS/LOSSES (M USD)

EQUITY (M USD)

LIABILITIES (M USD)

PROVISIONS (M USD)

OTHER SHORT-TERM LIABILITIES (M USD)OTHER SHORT-TERM LIAB. (M USD)

SHORT-TERM DEBTS (M USD)SHORT-TERM DEBTS (M USD)

SHORT-TERM PORTION OF LONG-TERM DEBTS (M USD)LONG-TERM DEBT PORTION (M USD)

SHORT-TERM RECEIVABLES (M USD)SHORT-TERM REC. (M USD)

LONG-TERM LIABILITIES (M USD)LONG-T. LIAB. (M USD)

DEFERRED TAXES (M USD)

OTHER LIABILITIES (M USD)OTHER LIAB. (M USD)

LONG-TERM LIABILITIES (M USD)LONG-T. LIABILITIES (M USD)

DEBT (M USD)

TOTAL CAPITAL (M USD)

1995	1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2022	2023	2024

3	1.1	2.6	2.6	1.4	2.9	2.5	6.7	19	15.1	10.6	27	12.9	13.3	13.7	27.3	50.4	70.8	146	111.1	143.2	175.8	247.1	277.9	234.8	311.9	239.8	239.83	288.4	330.42	181.77
0	100	100	300	500	400	300	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0.4	0	0	0.3	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
2.1	6.4	6.5	10.5	9.9	10.9	9.5	9.1	14.1	17.7	22.2	22.5	19.4	23.9	25.8	34.1	37	36.5	47.2	45.2	66.1	64.8	62.9	81.9	68.9	90.2	98.3	98.32	67.1	61.45	69.74
0.3	1	2	3.1	2.9	1.4	1.9	3	3.8	4.3	5.5	6.1	5.6	6.4	6.5	8.7	9.1	11.2	16.7	18.1	19.9	14.8	13.6	16.5	15.2	13.7	17.6	17.53	18.5	17.49	18.57
5.4	9	11.2	16.5	15	17	14.2	18.8	36.9	37.1	38.3	55.6	37.9	43.6	46	70.1	96.5	118.5	209.9	174.4	229.2	255.4	323.6	376.3	318.9	415.8	355.7	355.68	374	409.36	270.07
4.6	11.6	15	22.8	21.5	17.6	19.5	18.4	20.2	23.2	23.3	30.3	52.1	56.8	57.2	166.4	60.8	61.8	59.2	71.2	88	101.3	102.8	92	126.5	128.4	125.6	125.57	117.8	117.49	115.74
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	125.3	42.6	42.1	42.3	41	38.3	34.3	35.2	31.8	29.8	30.8	30.4	30.44	32.4	29.92	151.82
0	0	0	0	0	0	0	0	4.3	5.7	5.7	5.7	5.7	5.7	5.7	17.3	17.7	17.9	18.2	17.9	17.4	16.7	17.4	16.8	16.6	17.4	17.7	17.67	17.4	17.1	144.17
0.2	0.4	0.1	0.1	0.2	1	1.7	1.8	2.4	2	2.9	3.4	5.4	7.4	8.6	-174	17.3	13.1	19.7	29.6	35.3	40.5	23.7	21.5	14.7	39	38.9	38.94	44.6	30.51	57.27
4.8	12	15.1	22.9	21.7	18.6	21.2	20.2	26.9	30.9	31.9	39.4	63.2	69.9	71.5	135	138.4	134.9	139.4	159.7	179	192.8	179.1	162.1	187.6	215.6	212.6	212.62	212.2	215.01	469.01
10.2	21	26.3	39.4	36.7	35.6	35.4	39	63.8	68	70.2	95	101.1	113.5	117.5	205.1	234.9	253.4	349.3	334.1	408.2	448.2	502.7	538.4	506.5	631.4	568.3	568.31	586.2	624.38	739.08

6	6.8	7.2	9.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.02	0	0.02	0.02
0	0	0	-0.5	2.9	2.4	2.4	3.7	14.2	11.9	9.2	15.6	5.6	8.1	16.4	51.2	49.3	43.8	54.7	61.6	69.7	71.5	76.5	72	59.4	62.5	50	50.01	55.6	65.66	75.82
0.6	5.6	12.2	21.7	10.1	10.6	12.8	14.5	28.9	34.5	35.7	44.3	26.3	24.1	56.4	90.2	118.8	134.8	200	166.4	214.9	265.4	288.1	329.5	306.1	382.8	344.6	344.64	391.6	445.22	478.94
0	0	-0.1	-0.2	0	-0.1	-0.6	-0.1	1.2	1.5	0.8	0.4	1	-0.4	1.5	5.4	5.8	6.9	5.8	2.1	-3.8	-11.6	-1.4	-10.4	-13.9	-3.6	0.5	0.46	-12.8	-13.7	-22.67
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
6.6	12.4	19.3	30.1	13	12.9	14.6	18.1	44.3	47.9	45.7	60.3	32.9	31.8	74.3	146.8	173.9	185.5	260.5	230.1	280.8	325.3	363.2	391.1	351.6	441.7	395.1	395.12	434.4	497.2	532.11
1.2	4.7	3.2	4.2	4.1	3.4	2.6	2.7	5.2	5.1	5	10.2	8.1	6.9	5.8	6.4	8	7	9.5	7.8	10	9	11.8	9.9	12.5	18.2	13.5	13.51	11	10.07	11.98
0.5	1.3	1.4	1.8	1.5	1.3	1.2	3.5	5.9	6.7	8.6	11.1	14.3	15.1	12.2	19.1	16.5	21	25.9	28	34.6	34.9	34.3	40.4	40.8	53.3	50.8	50.78	35.5	32.71	43.47
1.9	1.1	2.1	2.7	6	2.8	3.9	5.1	8.9	11	13	18.5	23.5	32.5	22.5	33.5	35.2	42.8	60.5	72.9	86.8	94.5	95.1	98.3	82.8	96.6	96.5	96.51	97.3	75.28	61.17
0	1.5	0	0	2.8	7.2	4.1	2.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	2	0	2	3.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.79	23
3.6	8.6	6.7	8.7	16.4	14.7	13.8	17.6	20	22.8	26.6	39.8	45.9	54.5	40.5	59	59.7	70.8	95.9	108.7	131.4	138.4	141.2	148.6	136.1	168.1	160.8	160.79	143.8	118.85	139.63
0	0	0	0	7.5	8	6	2.6	0	0	0	0	28	35	7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0.1	0.4	0.6	0	0	1	0.8	0.8	1.1	1.4	0	0	0	0	9.8	9.9	10	10.9	10.6	9.8	5.5	13.7	13.4	10.3	12	7.5	7.5	4.1	4.55	4.07
0	0	0	0	0	0	0	0	0	0	0	0	2.3	1.2	1.6	1	0.9	0.9	1.2	1.1	1.2	1.4	1.1	1.3	18.8	19.2	14.3	14.33	14.2	12.16	18.16
0	0.1	0.4	0.6	7.5	8	7	3.4	0.8	1.1	1.4	0	30.3	36.2	8.6	10.8	10.8	10.9	12.1	11.7	11	6.9	14.8	14.7	29.1	31.2	21.8	21.83	18.3	16.71	22.24
3.6	8.7	7.1	9.3	23.9	22.7	20.8	21	20.8	23.9	28	39.8	76.2	90.7	49.1	69.8	70.5	81.7	108	120.4	142.4	145.3	156	163.3	165.2	199.3	182.6	182.62	162.1	135.56	161.86
10.2	21.1	26.4	39.4	36.9	35.6	35.4	39.1	65.1	71.8	73.7	100.1	109.1	122.5	123.4	216.6	244.4	267.2	368.5	350.5	423.2	470.6	519.2	554.4	516.8	641	577.7	577.74	596.5	632.76	693.97

Details

Balance Sheet

ⓘ

What Is the Balance Sheet?

The balance sheet is a financial snapshot of USANA Health Sciences at a specific point in time. It follows the fundamental equation: Assets = Liabilities + Shareholders' Equity. Unlike the income statement (which covers a period), the balance sheet tells you what the company owns, what it owes, and what belongs to shareholders at a given date.

Assets

Current assets (cash, receivables, inventory) can be converted to cash within 12 months and indicate short-term liquidity. Non-current assets (property, equipment, intangible assets, goodwill) represent long-term investments. A high proportion of cash and short-term investments gives USANA Health Sciences financial flexibility to weather downturns, fund acquisitions, or return capital to shareholders.

Liabilities

Current liabilities (accounts payable, short-term debt) are obligations due within one year. Non-current liabilities (long-term debt, pension obligations) are due further out. Key ratio to watch: the debt-to-equity ratio (Total Debt ÷ Shareholders' Equity). A ratio below 1.0 is generally healthy, meaning the company is funded more by equity than debt. Highly leveraged companies amplify both gains and losses.

Shareholders' Equity

Equity is the residual value belonging to shareholders after all debts are paid. It includes retained earnings (accumulated profits not paid out as dividends) and paid-in capital. Rising equity year over year is a positive sign — it means USANA Health Sciences is building book value. Declining equity, especially when driven by losses or heavy share buybacks funded by debt, warrants closer scrutiny.

Key Ratios to Derive

From the balance sheet, you can calculate the current ratio (current assets ÷ current liabilities; above 1.5 is comfortable), book value per share (equity ÷ shares outstanding), and return on equity (net income ÷ equity; above 15 % is strong). Tracking these ratios over time reveals whether USANA Health Sciences is strengthening or weakening its financial position.

NET INCOME (M USD)

DEPRECIATION AND AMORTIZATION M USDDEPRECIATION (M USD)

DEFERRED TAXES (M USD)

CHANGES IN WORKING CAPITAL (M USD)CHANGES IN WORKING CAPITAL (M USD)

NON-CASH ITEM (M USD)

PAID INTEREST (k USD)

PAID TAXES (M USD)

Net Cash Flow from Operating Activities (M USD)NET CASH FLOW FROM OPERATING ACTIVITIES (M USD)

CAPITAL EXPENDITURES (M USD)

CASH FLOW FROM INVESTING ACTIVITIES (M USD)CASH FLOW FROM INVESTING ACTIVITIES (M USD)

CASH FLOW FROM OTHER INVESTING ACTIVITIES (M USD)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M USD)

INTEREST INCOME AND EXPENSES (M USD)

NET DEBT CHANGE (M USD)NET DEBT CHANGE (M USD)

Net change in equity (M USD)NET CHANGE IN EQUITY (M USD)

CASH FLOW FROM FINANCING ACTIVITIES (M USD)CASH FLOW FROM FINANCING ACTIVITIES (M USD)

OTHER ITEMS OF FINANCING CASH FLOWS (M USD)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M USD)

TOTAL DIVIDENDS PAID (M USD)

NET CHANGE IN CASH FLOW (M USD)

FREE CASH FLOW (M USD)

SHARE-BASED COMPENSATION (M USD)

1994	1995	1996	1997	1998	1999			2000	2001	2002	2003	2004			2005	2006	2007	2008	2009		2010			2011	2012	2013	2014	2015			2016	2017	2018	2019	2020	2021	2022	2022	2023	2024
0	2	5	6	9	5	9	5	2	2	8	20	30	20	30	39	40	45	29	33	29	45	33	45	50	66	79	76	94	76	94	100	62	126	100	124	116	116	69	63	42
0	0	0	2	3	4	3	4	4	4	4	3	4	3	4	5	5	5	6	7	6	7	7	7	8	8	9	8	10	8	9	13	16	16	14	13	13	13	13	12	14
0	0	0	0	0	0	0	0	0	1	-1	0	0	0	0	0	-1	-1	-2	-2	-2	3	-2	3	-1	4	0	-1	-2	-1	-2	-3	19	0	-3	-2	-3	-2	-7	-2	-6
0	1	-1	-1	-3	0	-3	0	-3	1	2	9	0	9	0	1	13	3	5	-15	5	1	-15	1	1	6	9	25	10	25	10	10	7	-7	-8	0	-28	-28	6	-27	-13
0	0	0	0	1	4	1	4	0	0	1	1	1	1	1	1	7	12	13	18	6	18	9	8	21	17	7	4	10	-4	0	33	33	31	39	38	37	23	34	39	38
0	0	0	0	0	0	0	0	1,000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	4	3	5	4	5	4	4	1	3	2	9	2	9	15	19	25	20	22	20	21	22	21	24	27	27	27	35	26	35	52	46	70	54	53	59	59	45	42	40
0	3	4	7	10	15	10	15	4	10	15	35	38	35	38	48	61	58	46	32	46	66	32	66	70	92	98	105	111	105	111	137	123	152	126	160	121	121	103	70	60
0	-4	-7	-5	-11	-4	-11	-4	-5	-6	-3	-4	-7	-4	-7	-4	-11	-26	-16	-4	-16	-4	-4	-4	-10	-8	-8	-20	-23	-20	-23	-32	-13	-11	-16	-15	-12	-12	-16	-14	-213
0	-3	-7	-4	-11	-4	-11	-4	-2	-6	-2	-9	-9	-9	-9	-5	-11	-26	-15	-3	-15	-46	-3	-46	-10	-8	-21	-16	-25	-16	-25	-31	-12	-69	47	-34	-14	-14	-12	-11	-213
0	0	0	1	0	0	0	0	2	0	0	-5	-2	-5	-2	-1	0	0	0	0	0	-42	0	-42	0	0	-13	4	-1	4	-1	0	0	-57	64	-18	-1	-1	4	2	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	1	-1	0	10	0	10	2	-3	-3	-9	0	-9	0	0	0	28	7	-28	7	-7	-28	-7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	22
0	2	0	0	1	-23	1	-23	-2	0	-6	-4	-33	-4	-33	-46	-37	-76	-39	-1	-39	-5	-1	-5	-33	-68	-17	-127	-61	-127	-61	-64	-50	-105	-150	-57	-177	-177	-25	-11	-9
0	2	1	-1	1	-11	1	-11	0	-3	-9	-13	-33	-13	-33	-46	-33	-46	-29	-29	-29	-9	-29	-9	-33	-64	-10	-113	-49	-113	-49	-64	-50	-105	-152	-59	-181	-181	-30	-14	9
0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	4	1	2	0	2	2	0	2	0	3	7	14	12	14	12	0	0	0	-2	-2	-3	-3	-4	-3	-3
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	2	-1	1	0	-1	0	-1	1	0	4	12	-3	12	-3	-4	16	-14	0	0	0	10	0	10	26	20	66	-26	32	-26	32	32	71	-33	20	78	-72	-72	47	41	-148
0.3	-0.3	-3.6	1.8	-0.7	10.1	0	0	-1.2	3.4	12.9	30.9	31.2	0	0	43.7	50.3	31.9	29.9	28.4	0	61.9	0	0	59.5	84.4	90.8	84.8	87.8	0	0	104.3	110.6	140.7	110.1	145.3	108.4	0	87	56.15	-152.42
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Unlock the full history with 30+ years of data and forecast estimates.

Unlock all data — PRO

API Docs Get API Key

USANA Health Sciences Stock Quarterly Figures

REVENUE (M USD)

REVENUE GROWTH (%)

GROSS MARGIN (%)

GROSS INCOME (M USD)

NET INCOME (M USD)

NET INCOME GROWTH (%)

SHARES (M)

1995 Q1	1995 Q2	1995 Q3	1995 Q4	1996 Q1	1996 Q2	1996 Q3	1996 Q4	1997 Q1	1997 Q2	1997 Q3	1997 Q4	1998 Q1	1998 Q2	1998 Q3	1998 Q4	1999 Q1	1999 Q2	1999 Q3	1999 Q4	2000 Q1	2000 Q2	2000 Q3	2000 Q4	2001 Q1	2001 Q2	2001 Q3	2001 Q4	2002 Q1	2002 Q2	2002 Q3	2002 Q4	2003 Q1	2003 Q2	2003 Q3	2003 Q4	2004 Q1	2004 Q2	2004 Q3	2004 Q4	2005 Q1	2005 Q2	2005 Q3	2005 Q4	2006 Q1	2006 Q2	2006 Q3	2006 Q4	2007 Q1	2007 Q2	2007 Q3	2007 Q4	2008 Q1	2008 Q2	2008 Q3	2008 Q4	2009 Q1	2009 Q2	2009 Q3	2009 Q4	2010 Q1	2010 Q2	2010 Q3	2010 Q4	2011 Q1	2011 Q2	2011 Q3	2011 Q4	2012 Q1	2012 Q2	2012 Q3	2012 Q4	2013 Q1	2013 Q2	2013 Q3	2013 Q4	2014 Q1	2014 Q2	2014 Q3	2014 Q4	2015 Q1	2015 Q2	2015 Q3	2015 Q4	2016 Q1	2016 Q2	2016 Q3	2016 Q4	2017 Q1	2017 Q2	2017 Q3	2017 Q4	2018 Q1	2018 Q2	2018 Q3	2018 Q4	2019 Q1	2019 Q2	2019 Q3	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4e	2026 Q1e	2026 Q2e	2026 Q3e	2026 Q4e
3	5	7	8	10	14	16	15	17	21	22	23	26	30	32	32	31	32	32	33	31	31	30	29	27	28	29	28	28	32	34	38	40	47	52	59	61	66	67	74	75	80	81	85	85	89	92	98	100	107	106	108	101	109	107	111	97	112	110	116	119	126	135	137	143	148	143	145	154	160	165	168	169	189	173	186	182	188	191	227	219	233	233	232	240	258	254	252	255	257	261	273	292	301	296	299	273	256	260	271	266	259	298	310	308	336	274	267	272	264	233	228	248	238	213	221	227	212	200	213	249	235	213	230	242	228	231	235
–	66.67	40.00	14.29	25.00	40.00	14.29	-6.25	13.33	23.53	4.76	4.55	13.04	15.38	6.67	–	-3.13	3.23	–	3.13	-6.06	–	-3.23	-3.33	-6.90	3.70	3.57	-3.45	–	14.29	6.25	11.76	5.26	17.50	10.64	13.46	3.39	8.20	1.52	10.45	1.35	6.67	1.25	4.94	–	4.71	3.37	6.52	2.04	7.00	-0.93	1.89	-6.48	7.92	-1.83	3.74	-12.61	15.46	-1.79	5.45	2.59	5.88	7.14	1.48	4.38	3.50	-3.38	1.40	6.21	3.90	3.13	1.82	0.60	11.83	-8.47	7.51	-2.15	3.30	1.60	18.85	-3.52	6.39	–	-0.43	3.45	7.50	-1.55	-0.79	1.19	0.78	1.56	4.60	6.96	3.08	-1.66	1.01	-8.70	-6.23	1.56	4.23	-1.85	-2.63	15.06	4.03	-0.65	9.09	-18.45	-2.55	1.87	-2.94	-11.74	-2.15	8.77	-4.03	-10.50	3.76	2.71	-6.61	-5.66	6.50	16.90	-5.62	-9.36	7.98	5.22	-5.79	1.32	1.73
66.67	80.00	71.43	75.00	80.00	78.57	75.00	80.00	76.47	76.19	81.82	78.26	76.92	80.00	78.13	78.13	77.42	81.25	81.25	78.79	77.42	67.74	70.00	65.52	70.37	71.43	72.41	71.43	71.43	71.88	76.47	76.32	77.50	76.60	78.85	77.97	75.41	75.76	76.12	74.32	76.00	76.25	75.31	75.29	78.82	78.65	77.17	77.55	80.00	79.44	79.25	78.70	79.21	79.82	78.50	78.38	79.38	78.57	80.00	80.17	80.67	81.75	80.74	82.48	81.82	82.43	82.52	83.45	81.82	82.50	81.21	82.14	81.66	83.07	82.08	81.72	81.32	81.38	82.20	83.70	82.65	82.83	82.40	82.76	82.08	82.17	82.28	81.75	83.14	82.88	81.99	83.15	82.88	83.39	82.43	83.28	83.15	81.64	81.54	82.66	82.71	81.47	81.21	80.97	81.17	83.04	81.39	80.15	81.25	81.44	79.83	79.39	80.24	81.51	79.81	80.54	81.06	81.13	80.00	82.16	79.12	78.72	77.00	71.30	67.77	71.93	71.00	69.79
2	4	5	6	8	11	12	12	13	16	18	18	20	24	25	25	24	26	26	26	24	21	21	19	19	20	21	20	20	23	26	29	31	36	41	46	46	50	51	55	57	61	61	64	67	70	71	76	80	85	84	85	80	87	84	87	77	88	88	93	96	103	109	113	117	122	118	121	126	132	134	138	138	157	142	152	148	153	157	190	181	193	192	192	197	212	209	206	212	213	214	227	242	251	244	249	227	209	212	224	220	211	242	251	250	279	223	214	221	215	186	181	199	194	170	178	184	172	160	175	197	185	164	164	164	164	164	164
0	0	0	0	1	1	1	1	1	1	1	1	1	2	2	2	2	2	0	2	1	0	0	0	0	0	0	0	1	1	2	3	3	4	6	6	6	7	8	9	8	9	10	10	9	10	10	11	11	11	11	11	7	10	8	4	6	8	7	10	9	10	12	12	11	13	12	13	13	16	17	18	17	24	16	20	16	19	19	21	19	25	25	24	22	25	30	21	21	23	23	-5	28	33	31	32	24	21	24	30	26	28	30	39	30	38	27	20	22	19	14	12	18	17	11	16	16	10	10	4	9	9	-6	7	7	8	9	10
–	–	–	–	–	–	–	–	–	–	–	–	–	100.00	–	–	–	–	–	–	-50.00	–	–	–	–	–	–	–	–	–	100.00	50.00	–	33.33	50.00	–	–	16.67	14.29	12.50	-11.11	12.50	11.11	–	-10.00	11.11	–	10.00	–	–	–	–	-36.36	42.86	-20.00	-50.00	50.00	33.33	-12.50	42.86	-10.00	11.11	20.00	–	-8.33	18.18	-7.69	8.33	–	23.08	6.25	5.88	-5.56	41.18	-33.33	25.00	-20.00	18.75	–	10.53	-9.52	31.58	–	-4.00	-8.33	13.64	20.00	-30.00	–	9.52	–	-121.74	-660.00	17.86	-6.06	3.23	-25.00	-12.50	14.29	25.00	-13.33	7.69	7.14	30.00	-23.08	26.67	-28.95	-25.93	10.00	-13.64	-26.32	-14.29	50.00	-5.56	-35.29	45.45	–	-37.50	–	-60.00	125.00	–	-166.67	-216.67	–	14.29	12.50	11.11
42.5	42.5	45.1	44.6	50.2	50.3	50.7	50.6	53.8	53.1	53.1	53.5	55.1	56.3	56.8	54.8	54.2	53	49.9	41.5	40.8	39.4	39.1	38.9	38.9	38.9	38.8	38.7	38.7	42.5	42.4	41.5	42.1	42.9	42.8	42.8	41.7	41	40.6	40	39.9	39.6	39.5	38.7	38.5	37.6	37	36.8	36.9	34.3	33.2	33.2	32.9	32.9	32.3	31.3	30.8	30.8	31.1	31.1	31	31.4	32.5	33	32.4	31.5	30.4	30.4	30.6	30.2	29.8	28.9	27.8	28.2	28.8	28.8	28.8	28.6	26.5	25.7	26.2	26.5	26.6	26.2	25.2	24.9	25.1	25	25	25	24.6	24	24.3	24.8	25	24.5	23.9	23.4	22.2	21.8	21.6	21.1	21.2	21.2	21.1	20.4	20.2	19.7	19.5	19.2	19.3	19.3	19.3	19.4	19.4	19.25	19.3	19.16	19.08	19.11	19.09	18.54	18.29	18.29	18.29	18.29	18.29	18.29

Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Gross Margin

EBIT and EBIT Margin

Net Income and Earnings Per Share (EPS)

Shares Outstanding

Analyst Estimates

Unlock the full history with 30+ years of data and forecast estimates.

Unlock all data — PRO

API Docs Get API Key

USANA Health Sciences stock margins

The USANA Health Sciences margin analysis displays the gross margin, EBIT margin, as well as the profit margin of USANA Health Sciences. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for USANA Health Sciences.

3 Years
5 Years
10 Years
25 Years
Max

Gross margin

EBIT margin

Profit margin

Details

API Docs Get API Key

USANA Health Sciences Stock Sales Revenue, EBIT, Earnings per Share

The USANA Health Sciences earnings per share therefore indicates how much revenue USANA Health Sciences has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

3 Years
5 Years
10 Years
25 Years
Max

Sales per Share

EBIT per share

Earnings per Share

Details

API Docs Get API Key

USANA Health Sciences business model

USANA Health Sciences Inc is an American company that was founded in 1992 by Dr. Myron Wentz. Originally headquartered in Salt Lake City, Utah, the company now operates in over 20 countries worldwide. The main mission of USANA is to help people live healthier lives through high-quality supplements and a healthy lifestyle. USANA is a direct sales company, which means that its products are sold by independent distributors. These distributors earn a commission on their sales and can also have additional income opportunities by building a network of distributors. USANA's business model is based on the idea that people can improve their well-being and enhance their lives by using high-quality supplements and adopting a healthy lifestyle. USANA offers a wide range of products in various categories, including supplements for adults and children, weight management products, personalized vitamins and minerals, skincare products, as well as energy and fitness products. The quality of USANA's products is ensured through strict quality assurance measures and independent certification by NSF International, a third-party company that verifies the safety and efficacy of supplements. USANA also has several divisions, including USANA Health Sciences, Inc., USANA Pacific, Ltd., and BabyCare Ltd. USANA Health Sciences, Inc. is the company's main focus, specializing in the development and distribution of health-related products. USANA Pacific Ltd. is a wholly independent company that focuses on developing and distributing products for customers in Australia, New Zealand, and Asia. BabyCare Ltd. is a company specialized in manufacturing skincare products for babies. USANA has also established a charitable organization, the USANA Foundation, to carry out philanthropic work in various communities around the world. The USANA Foundation addresses basic needs such as health, education, and nutrition and supports organizations dedicated to helping children in need. In summary, USANA Health Sciences Inc is a company that is dedicated to improving people's health and well-being. Its direct sales model and use of high-quality ingredients and supplements certified by an independent third party have helped to build consumer trust in USANA's products. USANA has also expanded its reach through the establishment of various divisions and the creation of a charitable organization, allowing it to have a positive impact on many people worldwide.

API Docs Get API Key

USANA Health Sciences SWOT Analysis

Strengths

1. Strong Brand Reputation: USANA Health Sciences Inc has built a strong reputation in the health and wellness industry, known for its high-quality products and commitment to scientific research.

2. Extensive Product Line: The company offers a wide range of nutritional supplements, personal care products, and healthy food choices, catering to diverse customer needs.

3. Established Presence: With operations in multiple countries, USANA has a global presence, allowing it to tap into different markets and reach a larger customer base.

Weaknesses

1. Dependency on Distributor Network: USANA relies heavily on its network of independent distributors for sales and marketing, making it vulnerable to fluctuations in distributor performance and retention.

2. Intense Competition: The health and wellness market is highly competitive, with numerous established players and new entrants vying for market share. USANA needs to continuously innovate to stay ahead of the competition.

3. Product Pricing: USANA's products are priced at a premium compared to some competitors, limiting their accessibility to price-sensitive customers.

Opportunities

1. Growing Health Consciousness: The increasing consumer focus on health and wellness presents an opportunity for USANA to expand its customer base and market its products to individuals seeking healthier lifestyles.

2. Emerging Markets: USANA can explore and expand into emerging markets where there is a rising demand for health and wellness products, such as Asia and Latin America.

3. E-commerce Expansion: With the growing popularity of online shopping, USANA can invest in enhancing its e-commerce capabilities, allowing customers to conveniently purchase their products online.

Threats

1. Regulatory Challenges: The health and wellness industry is subject to stringent regulations and standards. USANA faces the risk of increased regulatory scrutiny, which could impact its operations and product offerings.

2. Economic Uncertainty: Global economic fluctuations and recessions can affect consumer spending on health products, potentially impacting USANA's revenue and profitability.

3. Negative Public Perception: Any adverse incidents or controversies related to the health and wellness industry can tarnish USANA's brand image and erode consumer trust.

API Docs Get API Key

USANA Health Sciences Segments

USANA Health Sciences Revenue by Region

3 Years
5 Years
10 Years
Max

Asia Pacific

Asia Pacific Total

Greater China

C [N]

China

Southeast Asia Pacific

Southeast Asia And Pacific

Americas and Europe

North Asia

KOREA, REPUBLIC OF

U [S]

United States

South Korea

Details

API Docs Get API Key

USANA Health Sciences Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

API Docs Get API Key

USANA Health Sciences historical P/E ratio, EBIT multiple, and P/S ratio

API Docs Get API Key

USANA Health Sciences annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

API Docs Get API Key

USANA Health Sciences shares outstanding

The number of shares was USANA Health Sciences in 2025 — This indicates how many shares 19.162 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

3 Years
5 Years
10 Years
25 Years
Max

Number of stocks

Details

API Docs Get API Key

USANA Health Sciences stock splits

In USANA Health Sciences's history, there have been no stock splits.

API Docs Get API Key

Current USANA Health Sciences forecasts and price targets in March 2026

Δ MOM Price Target	null %
Buy	null % (0)
Hold	50.00 % (3)
Sell	50.00 % (3)
12M Price Target	62.22
Last Price	23.39
Currency	USD
12M Return Potential	166.01 %
LTM Return	0 %

API Docs Get API Key

Unlock Earnings — PRO

USANA Health Sciences Earnings Estimates

Date	EPS estimate	Revenue Estimate	Quarterly report
2/17/2026	0.42USD	230.48 MUSD	2025 Q4
4/23/2024	0.75USD	230.72 MUSD	2024 Q1
2/5/2024	0.53USD	217.26 MUSD	2023 Q4
7/24/2023	1.02USD	255.02 MUSD	2023 Q2
4/24/2023	0.9USD	249.26 MUSD	2023 Q1
2/6/2023	0.36USD	206.84 MUSD	2022 Q4
10/25/2022	0.91USD	247.86 MUSD	2022 Q3
7/26/2022	1.16USD	272.48 MUSD	2022 Q2
4/26/2022	1.16USD	271.33 MUSD	2022 Q1
2/8/2022	1.31USD	276.01 MUSD	2021 Q4
10/26/2021	1.33USD	272.09 MUSD	2021 Q3
7/27/2021	1.75USD	337.6 MUSD	2021 Q2
4/27/2021	1.51USD	306 MUSD	2021 Q1
2/9/2021	1.46USD	295.92 MUSD	2020 Q4
10/20/2020	1.29USD	282.99 MUSD	2020 Q3
7/21/2020	1.1USD	260.17 MUSD	2020 Q2
4/21/2020	0.85USD	244.29 MUSD	2020 Q1
2/4/2020	1USD	256.54 MUSD	2019 Q4
10/22/2019	0.88USD	265.15 MUSD	2019 Q3
7/23/2019	0.95USD	258.4 MUSD	2019 Q2
4/30/2019	1.01USD	276.17 MUSD	2019 Q1
2/5/2019	1.35USD	312.31 MUSD	2018 Q4
10/23/2018	1.14USD	296.11 MUSD	2018 Q3
7/24/2018	1.13USD	285.38 MUSD	2018 Q2
4/24/2018	1.08USD	279 MUSD	2018 Q1
2/6/2018	1.02USD	261.67 MUSD	2017 Q4
10/24/2017	0.92USD	263.37 MUSD	2017 Q3
7/25/2017	1.17USD	288.71 MUSD	2017 Q2
5/2/2017	0.94USD	257.32 MUSD	2017 Q1
2/7/2017	0.96USD	257.32 MUSD	2016 Q4
10/25/2016	1.09USD	267.32 MUSD	2016 Q3
7/26/2016	1.05USD	260.51 MUSD	2016 Q2
5/3/2016	0.92USD	247.71 MUSD	2016 Q1
2/9/2016	1.01USD	242.49 MUSD	2015 Q4
11/3/2015	0.9USD	227.89 MUSD	2015 Q3
8/4/2015	0.82USD	216.13 MUSD	2015 Q2
5/5/2015	0.66USD	201.38 MUSD	2015 Q1
2/10/2015	0.98USD	222.03 MUSD	2014 Q4
10/28/2014	0.7USD	193.36 MUSD	2014 Q3
7/29/2014	0.77USD	201.27 MUSD	2014 Q2
4/29/2014	0.66USD	188.64 MUSD	2014 Q1
2/4/2014	0.62USD	178.28 MUSD	2013 Q4
10/22/2013	0.58USD	174.99 MUSD	2013 Q3
7/23/2013	0.68USD	179.05 MUSD	2013 Q2
4/23/2013	0.59USD	174.34 MUSD	2013 Q1
2/5/2013	0.62USD	168.29 MUSD	2012 Q4
10/23/2012	0.54USD	164.06 MUSD	2012 Q3
7/24/2012	0.47USD	157.35 MUSD	2012 Q2
4/24/2012	0.35USD	147.5 MUSD	2012 Q1
2/7/2012	0.44USD	146.57 MUSD	2011 Q4
10/25/2011	0.39USD	144.43 MUSD	2011 Q3
7/26/2011	0.41USD	149.54 MUSD	2011 Q2
4/26/2011	0.34USD	132.73 MUSD	2011 Q1
2/8/2011	0.43USD	138.97 MUSD	2010 Q4
10/26/2010	0.33USD	125.35 MUSD	2010 Q3
7/27/2010	0.32USD	124.85 MUSD	2010 Q2
4/27/2010	0.26USD	108.25 MUSD	2010 Q1
2/9/2010	0.3USD	117.4 MUSD	2009 Q4
10/27/2009	0.26USD	111.71 MUSD	2009 Q3
7/28/2009	0.23USD	101.49 MUSD	2009 Q2
4/28/2009	0.2USD	106.07 MUSD	2009 Q1
2/23/2009	0.29USD	113.7 MUSD	2008 Q4
10/14/2008	0.31USD	113.37 MUSD	2008 Q3
7/22/2008	0.31USD	109.84 MUSD	2008 Q2
4/21/2008	0.23USD	101.58 MUSD	2008 Q1
2/5/2008	0.34USD	111.01 MUSD	2007 Q4
10/16/2007	0.34USD	108.04 MUSD	2007 Q3
7/16/2007	0.32USD	105.77 MUSD	2007 Q2
4/17/2007	0.31USD	105.41 MUSD	2007 Q1
2/6/2007	0.3USD	101.37 MUSD	2006 Q4
10/17/2006	0.29USD	96.76 MUSD	2006 Q3
7/18/2006	0.27USD	94.64 MUSD	2006 Q2
4/18/2006	0.27USD	89.25 MUSD	2006 Q1
2/7/2006	0.26USD	88.51 MUSD	2005 Q4
10/18/2005	0.25USD	84.45 MUSD	2005 Q3
7/19/2005	0.24USD	80.29 MUSD	2005 Q2
4/19/2005	0.22USD	78.76 MUSD	2005 Q1
2/8/2005	0.21USD	72.32 MUSD	2004 Q4
10/19/2004	0.19USD	70.09 MUSD	2004 Q3
7/20/2004	0.17USD	65.28 MUSD	2004 Q2
4/20/2004	0.15USD	60.99 MUSD	2004 Q1
2/3/2004	0.15USD	57.85 MUSD	2003 Q4
10/14/2003	0.14USD	53.69 MUSD	2003 Q3

...

EESG©

Eulerpool ESG Scorecard© for the USANA Health Sciences stock

54/100

Environment

Social

Governance

Environment

Scope 1 - Direct Emissions1,429.7

Scope 2 - Indirect emissions from purchased energy935.9

Scope 3 - Indirect emissions within the value chain—

Total CO₂ emissions2,365.6

CO₂ reduction strategy

Coal energy

Nuclear power

Animal experiments

Fur & Leather—

Pesticides—

Palm Oil—

Tobacco

Genetically modified organisms

Climate concept—

Sustainable forestry—

Recycling regulations

Environmentally friendly packaging

Hazardous substances

Fuel consumption and efficiency

Water consumption and efficiency

Social

Percentage of female employees58

Percentage of women in management—

Percentage of Asian employees55

Share of Asian management55

Percentage of Hispanic/Latino employees14

Hispano/Latino Management share6

Percentage of Black employees1

Black Management Share—

Percentage of white employees27

White Management Share37

Adult content

Alcohol

Weapons—

Firearms

Gambling

Military contracts

Human rights concept

Privacy concept—

Occupational health and safety

Catholic

Governance (Corporate Governance)

Environmental reporting

Stakeholder Engagement

Call Back Policies

Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

API Docs Get API Key

USANA Health Sciences shareholders

%	Name	Stocks	Change	Date
42.34871%	Gull Global, Ltd.	7,741,345	-142,398	3/10/2025
8.43346%	BlackRock Institutional Trust Company, N.A.	1,541,637	-78,007	6/30/2025
6.63341%	Pzena Investment Management, LLC	1,212,588	+14,328	9/30/2025
6.31745%	Renaissance Technologies LLC	1,154,830	+69,566	6/30/2025
5.41455%	The Vanguard Group, Inc.	989,779	-362,125	6/30/2025
5.00574%	Dimensional Fund Advisors, L.P.	915,049	+17,318	9/30/2025
2.33230%	State Street Investment Management (US)	426,344	-25,022	6/30/2025
1.91797%	Jacobs Levy Equity Management, Inc.	350,605	+162,094	6/30/2025
1.69870%	Geode Capital Management, L.L.C.	310,523	-9,731	6/30/2025
1.39513%	American Century Investment Management, Inc.	255,029	-213	6/30/2025
1.24802%	Charles Schwab Investment Management, Inc.	228,138	+54,141	6/30/2025
0.93329%	Parametric Portfolio Associates LLC	170,606	+46,161	6/30/2025
0.91011%	Citadel Advisors LLC	166,368	+28,073	6/30/2025
0.85546%	Morgan Stanley & Co. LLC	156,378	-16,836	6/30/2025
0.82106%	Columbia Threadneedle Investments (US)	150,090	+58,921	6/30/2025
0.69055%	Goldman Sachs Asset Management, L.P.	126,232	+101,436	6/30/2025
0.67007%	Millennium Management LLC	122,488	-7,122	6/30/2025
0.61421%	Northern Trust Investments, Inc.	112,278	-9,221	6/30/2025
0.60137%	Aperio Group, LLC	109,931	+39,849	6/30/2025
0.55901%	Assenagon Asset Management S.A.	102,187	-2,223	9/30/2025
0.55129%	Nuveen LLC	100,775	+67,901	6/30/2025
0.53357%	Connor, Clark & Lunn Investment Management Ltd.	97,537	+65,268	6/30/2025
0.52858%	Invesco Capital Management LLC	96,624	+1,317	6/30/2025
0.41365%	D. E. Shaw & Co., L.P.	75,616	-71,032	6/30/2025
0.39861%	BofA Global Research (US)	72,865	+18,244	6/30/2025
0.36570%	Algert Global LLC	66,850	+66,850	6/30/2025
0.35967%	BlackRock Financial Management, Inc.	65,747	-9,433	6/30/2025
0.29940%	Mellon Investments Corporation	54,731	-3,295	6/30/2025
0.29312%	Principal Global Investors (Equity)	53,582	-1,494	6/30/2025
0.28921%	Bridgeway Capital Management, LLC	52,867	+2,384	6/30/2025
0.27822%	Nordea Funds Oy	50,859	-777	9/30/2025
0.27341%	Royce Investment Partners	49,979	+5,144	6/30/2025
0.27284%	Two Sigma Investments, LP	49,875	+49,875	6/30/2025
0.25823%	Exchange Traded Concepts, LLC	47,204	+39,297	9/30/2025
0.25071%	Walleye Capital LLC	45,829	+33,001	6/30/2025
0.24463%	UBS Financial Services, Inc.	44,718	-8,017	6/30/2025
0.22458%	BlackRock Investment Management, LLC	41,053	+6,747	6/30/2025
0.22228%	Goldman Sachs & Company, Inc.	40,632	-11,129	6/30/2025
0.20911%	Barclays Bank PLC	38,226	+9,096	6/30/2025
0.20746%	6 Meridian LLC	37,924	+37,924	9/30/2025
0.20159%	PSP Investments	36,851	+1,788	6/30/2025
0.19897%	Dimensional Fund Advisors, Ltd.	36,371		9/30/2025
0.19760%	DWS Investments UK Limited	36,121	+964	6/30/2025
0.19653%	Teacher Retirement System of Texas	35,925	+10,442	9/30/2025
0.18619%	Rhumbline Advisers Ltd. Partnership	34,036	-2,269	6/30/2025
0.17018%	Verition Fund Management LLC	31,108	+31,108	6/30/2025
0.16121%	Guest (Kevin G)	29,469	+1	3/10/2025
0.16082%	Legal & General Investment Management Ltd.	29,397	-355	6/30/2025
0.15729%	BlackRock Advisors (UK) Limited	28,752	+147	9/30/2025
0.15245%	ETF Architect	27,867	+2,384	6/30/2025
0.15066%	Acadian Asset Management LLC	27,541	+15,806	6/30/2025
0.13798%	Aquatic Capital Management LLC	25,223	+15,569	6/30/2025
0.13660%	BlackRock Asset Management Ireland Limited	24,970	-4,610	6/30/2025
0.13185%	Brown (Jim H)	24,102	+1,218	7/24/2025
0.12879%	Numeric Investors LLC	23,542	-45,286	6/30/2025
0.12867%	Ohio Public Employees Retirement System	23,520	+7,943	6/30/2025
0.12692%	Lazard Asset Management, L.L.C.	23,201	+13,128	6/30/2025
0.12037%	Vanguard Investments Australia Ltd.	22,004		6/30/2025
0.11858%	BNY Mellon Asset Management	21,676	+892	6/30/2025
0.11816%	Schweizerische Nationalbank	21,600	-700	6/30/2025
0.11800%	PGIM Quantitative Solutions LLC	21,571	-669	6/30/2025
0.11462%	Susquehanna International Group, LLP	20,952	-4,449	6/30/2025
0.11427%	PIMCO (US)	20,889	+20,889	6/30/2025
0.10969%	Creative Planning, Inc.	20,051	+613	6/30/2025
0.10947%	Quadrant Family Wealth Advisors	20,011	+13,159	6/30/2025
0.10886%	KLP Kapitalforvaltning AS	19,900		9/30/2025
0.10358%	Martingale Asset Management, L.P.	18,934	+1,392	6/30/2025
0.09985%	UBS Asset Management (Switzerland)	18,253	+10,376	6/30/2025
0.09850%	Mariner Wealth Advisors	18,006	-416	6/30/2025
0.09847%	State Teachers Retirement System of Ohio	18,000	+14,600	9/30/2025
0.09847%	Unison Advisors LLC	18,000		6/30/2025
0.09248%	Tidal Investments LLC	16,906	+5,318	6/30/2025
0.08996%	Inspire Investing	16,444	+16,444	9/30/2025
0.08976%	Denali Advisors, LLC	16,409		6/30/2025
0.08838%	Horizon Investments, LLC	16,155	+3,299	6/30/2025
0.08280%	State of Wisconsin Investment Board	15,136	+15,136	6/30/2025
0.08197%	Invesco Advisers, Inc.	14,985	-1,088	6/30/2025
0.07979%	AQR Capital Management, LLC	14,586	-7,259	6/30/2025
0.07928%	Research Affiliates, LLC	14,493	+14,493	6/30/2025
0.07867%	Citi Investment Research (US)	14,380	-3,670	6/30/2025
0.07834%	Vident Asset Management	14,321	+14,321	6/30/2025
0.07580%	Polymer Capital Management (US), LLC	13,857	+13,857	6/30/2025
0.07559%	Arrowstreet Capital, Limited Partnership	13,818	+13,818	6/30/2025
0.06931%	AllianceBernstein L.P.	12,670	+1,600	6/30/2025
0.06893%	New York State Teachers' Retirement System	12,600	+114	9/30/2025
0.06513%	Franklin Advisers, Inc.	11,905	+1,659	6/30/2025
0.06477%	Versor Investments LP	11,840	-1,160	6/30/2025
0.06411%	Magnetar Capital Partners LP	11,720	-303	6/30/2025
0.06253%	Numerai Gp LLC	11,430	-10,558	6/30/2025
0.06224%	Jump Financial, LLC	11,377	+11,377	6/30/2025
0.05848%	California State Teachers Retirement System	10,690		6/30/2025
0.05722%	T. Rowe Price International Ltd	10,460	+1,521	6/30/2025
0.05578%	HSBC Global Asset Management (UK) Limited	10,196	-4,554	6/30/2025
0.05530%	Jane Street Capital, L.L.C.	10,109	-29,302	6/30/2025
0.05449%	BlackRock Investment Management (UK) Ltd.	9,961		6/30/2025
0.05357%	SEI Investments Management Corporation	9,793		9/30/2025
0.05281%	Centiva Capital, LP	9,653	-1,832	6/30/2025
0.05071%	SG Americas Securities, L.L.C.	9,269	+9,269	9/30/2025
0.05066%	Mulham (David Mulham)	9,260	-3,515	7/30/2025
0.05056%	BNP Paribas Securities Corp. North America	9,243	+8,379	6/30/2025

...

API Docs Get API Key

USANA Health Sciences Executives and Management Board

Mr. Jim Brown

(56)

President, Chief Executive Officer

Compensation3.36 MUSD

Compensation3.36 M USD

Mr. Kevin Guest

(62)

Executive Chairman of the Board · since 2004

1.82 MUSD

Compensation1.82 M USD

Mr. G. Hekking

(55)

Chief Financial Officer

1.44 MUSD

Compensation1.44 M USD

Mr. Walter Noot

(59)

Chief Operating Officer

1.44 MUSD

Compensation1.44 M USD

Mr. Brent Neidig

(41)

Chief Commercial Officer

1.3 MUSD

Compensation1.3 M USD

API Docs Get API Key

USANA Health Sciences Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite

1 companies

#	Name	1M	3M	6M	1Y	2Y	Trend
1	Verint Systems Supplier	0,82	-0,07	-0,02	-0,45	0,53

API Docs Get API Key

USANA Health Sciences Research

Soon

Deep-dive analyses, investment theses, and proprietary research — curated by Eulerpool.

Research reports are coming soon

We're building institutional-grade equity research for USANA Health Sciences and thousands of other companies.

Most common questions regarding USANA Health Sciences

USANA Health Sciences Inc operates through a direct selling business model. The company manufactures and distributes science-based nutritional and personal care products. USANA's business model involves independent associates who sell its products directly to customers, earning commissions and bonuses based on their sales and the sales of their team. This model allows USANA to bypass traditional retail channels and establish a strong relationship with its customers. With a focus on health and wellness, USANA Health Sciences Inc aims to provide high-quality products that promote a healthy lifestyle and support optimal well-being.

API Docs Get API Key

Fair ValuePRO

18.98 USD

Over-/UndervaluationPRO

20.0% undervalued

Expected Return

18.8 %

Sector

Non-cyclical consumption

Industry

Personal Products

Number of shares

18,280,000

Employees

1,909

Revenue per Employee

447,618.12 USD

Revenue growth Ø5 years

-5.51 %

EBIT growth Ø5 years

-17.78 %

Net Income growth Ø5 years

-19.55 %

Website usana.com

Country

United States 🇺🇸

Currency

USD

Initial public offering

Oct 28, 1993

ISIN

US90328M1071

Cusip

90328M107

Sedol

2267698

Market capitalization

347.34 M USDSmall Cap

52-Week Range

19.06–21.93USD

USANA Health Sciences Directors Dealings

Quality Investing

Details

3 / 10

Sales growth (10Y) > 5%

Revenue growth (3Y) > 5 %

EBIT growth (10Y) > 5%

EBIT growth (3Y) > 5 %

Net debt < 4x EBIT

Profitable since 10Y+

EBIT Drawdown (10Y) < 50%

Return on Equity (ROE) > 15%

ROCE > 15%

Return Expectation > 10%

PEG

0.57

P/E ratio

9.95

P/Ee 2025

12.88

P/Ee 2026

11.5

P/Ee 2027

7.98

P/S

0.49

P/Se

0.44

EV/EBIT

2.84

P/B Ratio

0.65

ROE (Return on Equity)

7.9 %

ROA (Return on Assets)

5.62 %

ROCE (Return on Capital Employed)

12.46 %

ROIC (Return on Invested Capital)

11.26 %

PROUnlock all valuation metrics

Gross Margin

81.13 %

EBIT Margin

7.76 %

Net Margin

4.92 %

EPS (Earnings Per Share)

2.19 USD

Net Debt / EBIT

-2.39

Debt/Equity

0.04

Last updated Mar 3, 2026, 3:42 PM

USANA Health Sciences Peer Group

Coty Inc

Estee Lauder Companies Inc

Medifast IncPRO

Interparfums IncPRO

Edgewell Personal Care CoPRO

NU Skin Enterprises IncPRO

USANA Health Sciences Ticker

FRANKFURT · USJ.FMUNICH · USJ.MUNEW YORK · USNASIX · USJ.SW

USANA Health Sciences FIGI

USNA:US · BBG000BX28M0USNA:UA · BBG000BX29L9USNA:UC · BBG000BX2B52USNA:UN · BBG000BX2BQ9USNA:UP · BBG000BX2CG8USNA:UB · BBG000BX2DL0USNA:UT · BBG000BX2DR4USNA:UM · BBG000BX2FG1USNA:UX · BBG000BX2FW3USNA:UD · BBG000BX2JY3USNA:UF · BBG000BX2L87USNA:VY · BBG000BX2LL2USNA:VJ · BBG000BX2LZ7USNA:VK · BBG000BX2MJ3USJ:GR · BBG000L0XWL5USJ:GF · BBG000L0YYF7USJ:GS · BBG000L103J6USJ:GM · BBG000L103W1USNA:VF · BBG00DJD6F11USJ:GZ · BBG00FGX0YF5USNAEUR:X2 · BBG00JPC6V09USNAEUR:XB · BBG00JPC6V18USNAEUR:XH · BBG00JPC6V36USNAEUR:XF · BBG00JPC6V54USNAEUR:XE · BBG00JPC6V72USNAEUR:XJ · BBG00JPC6V81USNAEUR:XL · BBG00JPC6V90USNAEUR:XG · BBG00JPC6VB7USNAEUR:XO · BBG00JPC6VC6USNAEUR:XS · BBG00JPC6VH1USNAEUR:XA · BBG00JPC6VJ9USNAEUR:E1 · BBG00JPC6VK7USNAEUR:XT · BBG00JPC6VL6USNAEUR:XW · BBG00JPC6VM5USNAEUR:XU · BBG00JPC6VN4USNAEUR:XV · BBG00JPC6VP2USNAEUR:XM · BBG00JPC6VQ1USNAEUR:XQ · BBG00JPC6VS9USNAEUR:XX · BBG00JPC6VT8USNAEUR:XZ · BBG00JPC6VV5USNAEUR:EU · BBG00JPC6VX3USNAUSD:XS · BBG00KL6R295USNAUSD:XH · BBG00KL6R2D0USNAUSD:XF · BBG00KL6R2G7USNAUSD:XE · BBG00KL6R2J4USNAUSD:XJ · BBG00KL6R2K2USNAUSD:XL · BBG00KL6R2L1USNAUSD:XG · BBG00KL6R2M0USNAUSD:XO · BBG00KL6R2N9USNAUSD:XA · BBG00KL6R2S4USNAUSD:E1 · BBG00KL6R2T3USNAUSD:XT · BBG00KL6R2V0USNAUSD:XW · BBG00KL6R2W9USNAUSD:XU · BBG00KL6R2X8USNAUSD:XV · BBG00KL6R2Y7USNAUSD:XM · BBG00KL6R2Z6USNAUSD:XQ · BBG00KL6R311USNAUSD:XX · BBG00KL6R320USNAUSD:XZ · BBG00KL6R339USNAUSD:EU · BBG00KL6R357USNAGBP:XS · BBG00L2TPFD2USNAGBP:XH · BBG00L2TPFH8USNAGBP:XF · BBG00L2TPFL3USNAGBP:XE · BBG00L2TPFN1USNAGBP:XJ · BBG00L2TPFP9USNAGBP:XL · BBG00L2TPFQ8USNAGBP:XG · BBG00L2TPFR7USNAGBP:XO · BBG00L2TPFS6USNAGBP:XA · BBG00L2TPFY9USNAGBP:E1 · BBG00L2TPFZ8USNAGBP:XT · BBG00L2TPG04USNAGBP:XW · BBG00L2TPG13USNAGBP:XU · BBG00L2TPG22USNAGBP:XV · BBG00L2TPG31USNAGBP:XM · BBG00L2TPG40USNAGBP:XQ · BBG00L2TPG77USNAGBP:XX · BBG00L2TPG86USNAGBP:XZ · BBG00L2TPG95USNAGBP:EU · BBG00L2TPGG7USJ:SW · BBG00LVGHYV6USJ:BW · BBG00LVGHZ16USNA:VG · BBG00X1LJY04USNA:VP · BBG00X1PZ6Z0USNAUSD:EP · BBG00XDH9KN6USNAUSD:EZ · BBG00XDH9KQ3USJ:LA · BBG018H7SRR8USJ:LU · BBG018J1FVC0

All fundamentals about USANA Health Sciences

Our stock analysis for USANA Health Sciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of USANA Health Sciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

USANA Health Sciences Revenue→

USANA Health Sciences Net Income→

USANA Health Sciences P/E→

USANA Health Sciences P/S→

USANA Health Sciences EBIT→

USANA Health Sciences Dividend→

USANA Health Sciences Directors Dealings→

USANA Health Sciences Stocks→

USANA Health Sciences Market capitalization→

USANA Health Sciences Debt→

USANA Health Sciences Liabilities→

USANA Health Sciences Equity→